Nasdaq: IAM
Iambic Therapeutics insiders
The officers, directors and 10% owners of Iambic Therapeutics, Inc. who hold the most stock, valued at the live IAM price.
$14.26
IAM today −$500K (−3.39%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their IAM stock
- $53.5M
- Market value
- $676M
- Held by ranked insiders
- 7.92%
Insiders by value of IAM holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Frederick R. Manby | Chief Technology Officer | 1,862,665 | $26.6M | 3.93% | 4175th |
| 2 | Thomas F. Miller | Chief Executive Officer | 1,410,756 | $20.1M | 2.98% | 5014th |
| 3 | Michael Secora | CFO & Chief Corp Dev Ofcr | 279,902 | $4.0M | 0.59% | 10344th |
| 4 | William H. Rastetter | Director | 200,920 | $2.9M | 0.42% | 8559th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Iambic Therapeutics; see each profile for the filing.